Clinical Trial

Orthorexia Nervosa in Fibromyalgia

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 27, 2025 (before its estimated May 20, 2025 completion). Its status may not reflect the trial's current state.
Summary
This clinical cross-sectional study will include 84 female patients aged between 18 and 65 years who have been diagnosed with fibromyalgia syndrome according to the 2010 American College of Rheumatology diagnostic criteria. Sociodemographic data will be recorded at the beginning of the study. Pain severity will be assessed using the Visual Analog Scale (VAS). Orthorexia nervosa-related symptoms will be evaluated with the ORTO-11 scale. Body image will be assessed with the Body Appreciation Scale 2, mood will be evaluated using the Hospital Anxiety and Depression Scale (HADS), and fibromyalgia-related impact will be assessed with the Fibromyalgia Impact Questionnaire (FIQ).
Trial Details
NCT Number NCT06947200
Lead Sponsor Beylikduzu State Hospital
Conditions Fibromyalgia
Enrollment 84 participants
Start Date 2025-04-20
Primary Completion 2025-05-20 (estimated)
Study Completion 2025-05-20 (estimated)
Updated on ClinicalTrials.gov 2025-04-27